We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

THERMO FISHER SCIENTIFIC

Thermo Fisher Scientific provides analytical instruments, lab equipment, specialty diagnostics, reagents and integrat... read more Featured Products: More products

Download Mobile App





Thermo Fisher Showcases Transformative Diagnostic Solutions

By LabMedica International staff writers
Posted on 29 Jul 2025

Thermo Fisher Scientific Inc. More...

(Waltham, MA; USA) is showcasing its comprehensive diagnostics solutions to help effectively assess clinical risk and diagnose disease, advance precision medicine, and further clinical research. Thermo Fisher is offering dynamic activities throughout the week, including more than 20 short lectures on various topics designed to help elevate laboratory performance and capabilities.

Visitors to Thermo Fisher’s booth at ADLM 2025 can experience its solutions firsthand during personalized product demonstrations and learn how the company’s diagnostics solutions help transform patient care. Visitors can also request tailored product demonstrations or schedule time to discuss solutions to help address their lab's needs. At ADLM 2025, Thermo Fisher is presenting new technologies and testing solutions that could enhance scientific results, boost operational efficiency, and advance clinical capabilities. Thermo Fisher is showcasing Aesku’s portfolio of FDA-cleared IFA products, automated instruments, like the Helios HTC, and software.

Thermo Fisher is also highlighting EliA assays, which help provide unparalleled focus on automation and workflow efficiency to support earlier diagnosis and improve care for patients with autoimmune conditions. Enabling faster and more accurate diagnoses for patients with complex autoimmune conditions, the Helios IFA System, together with the EliA portfolio, run on Phadia Laboratory Systems, meets the evolving needs of laboratories and allows for more efficient workflows by providing the most comprehensive suite of automated diagnostic systems and methodologies available in the U.S. market.

Binding Site, part of Thermo Fisher, is also participating in ADLM 2025, where it is showcasing its Optilite analyzer for special protein analysis that features an extensive assay menu for comprehensive testing options. The compact Optilite system features fully automated dilutions plus unrestricted access for samples and reagents, enabling a streamlined workflow for the entire laboratory. The Optilite system utilizes proven turbidimetric technology, which is known to be fast, robust, and versatile, becoming the main technology for protein diagnostics worldwide. Combining the Optilite system’s ease of use with Binding Site’s high-quality latex-enhanced assays gives peace of mind and the freedom to allocate time and resources in the most efficient way. Visitors can also experience Binding Site’s future innovative solution, the EXENT System, a mass spectrometry solution for M-protein assessment.

Related Links:
Thermo Fisher Scientific Inc.


New
Gold Member
Hematology Analyzer
Medonic M32B
Portable Electronic Pipette
Mini 96
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Specimen Radiography System
TrueView 200 Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Dormant tumor cells evade imaging tests and may later reactivate to spread metastatic breast cancer (Photo courtesy of David A. Litman/Shutterstock)

MRD Testing Can Identify Breast Cancer Survivors at Higher Risk of Recurrence

Breast cancer survival rates continue to improve, but recurrence remains incurable and affects around 30% of patients. Some subtypes, like triple negative and HER2+, relapse within years, while ER+ cancers... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.